mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.008 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.009 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |